B-intervention	0	8	Decision
I-intervention	9	12	aid
O	13	15	on
O	16	22	breast
O	23	29	cancer
O	30	39	screening
O	40	47	reduces
O	48	58	attendance
O	59	63	rate
O	63	64	:
O	65	72	results
O	73	75	of
O	76	77	a
O	78	83	large
O	83	84	-
O	84	89	scale
O	89	90	,
O	91	101	randomized
O	101	102	,
O	103	113	controlled
O	114	119	study
O	120	122	by
O	123	126	the
O	127	134	DECIDEO
O	135	140	group
O	140	141	.

O	142	155	Controversies
O	156	165	regarding
O	166	169	the
O	170	178	benefits
O	179	181	of
O	182	188	breast
O	189	195	cancer
O	196	205	screening
O	206	214	programs
O	215	219	have
O	220	223	led
O	224	226	to
O	227	230	the
O	231	240	promotion
O	241	243	of
O	244	247	new
O	248	258	strategies
O	259	265	taking
O	266	270	into
O	271	278	account
O	279	289	individual
O	290	301	preferences
O	301	302	,
O	303	307	such
O	308	310	as
O	311	319	decision
O	320	323	aid
O	323	324	.

O	325	328	The
O	329	332	aim
O	333	335	of
O	336	340	this
O	341	346	study
O	347	350	was
O	351	353	to
O	354	360	assess
O	361	364	the
O	365	371	impact
O	372	374	of
O	375	376	a
O	377	385	decision
O	386	389	aid
O	390	397	leaflet
O	398	400	on
O	401	404	the
O	405	418	participation
O	419	421	of
O	422	427	women
O	428	435	invited
O	436	438	to
O	439	450	participate
O	451	453	in
O	454	455	a
O	456	464	national
O	465	471	breast
O	472	478	cancer
O	479	488	screening
O	489	496	program
O	496	497	.

O	498	502	This
O	503	513	Randomized
O	513	514	,
O	515	526	multicentre
O	526	527	,
O	528	538	controlled
O	539	544	trial
O	544	545	.

O	546	551	Women
O	552	556	aged
B-age	557	559	50
I-age	560	562	to
I-age	563	565	74
I-age	566	571	years
O	571	572	,
O	573	577	were
O	578	586	randomly
O	587	595	assigned
O	596	598	to
O	599	606	receive
O	607	613	either
O	614	615	a
O	616	624	decision
O	625	628	aid
O	629	631	or
O	632	635	the
B-control	636	641	usual
I-control	642	652	invitation
I-control	653	659	letter
O	659	660	.

O	661	668	Primary
O	669	676	outcome
O	677	680	was
O	681	684	the
B-outcome-Measure	685	698	participation
I-outcome-Measure	699	703	rate
I-outcome-Measure	704	706	12
I-outcome-Measure	707	713	months
I-outcome-Measure	714	719	after
I-outcome-Measure	720	723	the
I-outcome-Measure	724	734	invitation
O	734	735	.

B-total-participants	736	738	16
I-total-participants	739	742	000
O	743	748	women
O	749	753	were
O	754	764	randomized
O	765	768	and
B-total-participants	769	771	15
I-total-participants	772	775	844
O	776	784	included
O	785	787	in
O	788	791	the
O	792	800	modified
O	801	810	intention
O	810	811	-
O	811	813	to
O	813	814	-
O	814	819	treat
O	820	828	analysis
O	828	829	.

O	830	833	The
B-outcome	834	847	participation
I-outcome	848	852	rate
O	853	855	in
O	856	859	the
O	860	872	intervention
O	873	878	group
O	879	882	was
B-iv-bin-percent	883	885	40
I-iv-bin-percent	885	886	.
I-iv-bin-percent	886	888	25
I-iv-bin-percent	888	889	%
O	890	891	(
B-iv-bin-abs	891	895	3174
O	895	896	/
B-intervention-participants	896	900	7885
O	901	906	women
O	906	907	)
O	908	916	compared
O	917	921	with
B-cv-bin-percent	922	924	42
I-cv-bin-percent	924	925	.
I-cv-bin-percent	925	927	13
I-cv-bin-percent	927	928	%
O	929	930	(
B-cv-bin-abs	930	934	3353
O	934	935	/
B-control-participants	935	939	7959
O	939	940	)
O	941	943	in
O	944	947	the
O	948	955	control
O	956	961	group
O	962	963	(
O	963	964	p
O	965	966	=
O	967	968	0
O	968	969	.
O	969	971	02
O	971	972	)
O	972	973	.

B-outcome	974	982	Previous
I-outcome	983	993	attendance
I-outcome	994	997	for
I-outcome	998	1007	screening
O	1008	1009	(
O	1009	1011	RR
O	1012	1013	=
O	1014	1015	6
O	1015	1016	.
O	1016	1018	24
O	1018	1019	;
O	1020	1021	[
O	1021	1023	95
O	1023	1024	%
O	1024	1026	IC
O	1026	1027	:
O	1028	1029	5
O	1029	1030	.
O	1030	1032	75
O	1032	1033	-
O	1033	1034	6
O	1034	1035	.
O	1035	1037	77
O	1037	1038	]
O	1038	1039	;
O	1040	1041	p
O	1042	1043	<
O	1044	1045	0
O	1045	1046	.
O	1046	1050	0001
O	1050	1051	)
O	1052	1055	and
B-outcome	1056	1062	medium
I-outcome	1063	1072	household
I-outcome	1073	1079	income
O	1080	1081	(
O	1081	1083	RR
O	1084	1085	=
O	1086	1087	1
O	1087	1088	.
O	1088	1090	05
O	1090	1091	;
O	1092	1093	[
O	1093	1095	95
O	1095	1096	%
O	1096	1098	IC
O	1098	1099	:
O	1100	1101	1
O	1101	1102	.
O	1102	1104	01
O	1104	1105	-
O	1105	1106	1
O	1106	1107	.
O	1107	1109	09
O	1109	1110	]
O	1110	1111	;
O	1112	1113	p
O	1114	1115	=
O	1116	1117	0
O	1117	1118	.
O	1118	1122	0074
O	1122	1123	)
O	1124	1128	were
O	1129	1142	independently
O	1143	1153	associated
O	1154	1158	with
O	1159	1169	attendance
O	1170	1173	for
O	1174	1183	screening
O	1183	1184	.

O	1185	1189	This
O	1190	1195	large
O	1195	1196	-
O	1196	1201	scale
O	1202	1207	study
O	1208	1220	demonstrates
O	1221	1225	that
O	1226	1229	the
O	1230	1238	decision
O	1239	1242	aid
O	1243	1250	reduced
O	1251	1254	the
O	1255	1268	participation
O	1269	1273	rate
O	1273	1274	.

O	1275	1278	The
O	1279	1287	decision
O	1288	1291	aid
O	1292	1300	activate
O	1301	1304	the
O	1305	1313	decision
O	1314	1320	making
O	1321	1328	process
O	1329	1331	of
O	1332	1337	women
O	1338	1344	toward
O	1345	1348	non
O	1348	1349	-
O	1349	1359	attendance
O	1360	1362	to
O	1363	1372	screening
O	1372	1373	.

O	1374	1379	These
O	1380	1387	results
O	1388	1392	show
O	1393	1396	the
O	1397	1407	importance
O	1408	1410	of
O	1411	1420	promoting
O	1421	1429	informed
O	1430	1437	patient
O	1438	1445	choices
O	1445	1446	,
O	1447	1457	especially
O	1458	1462	when
O	1463	1468	those
O	1469	1476	choices
O	1477	1483	cannot
O	1484	1486	be
O	1487	1498	anticipated
O	1498	1499	.
